The Impact of the Covid-19 Pandemic on Schizophrenia Patients Registered With the Community Mental Health Center

Republic of Turkey Ministry of Health

Status: Completed

Conditions: Schizophrenia

Treatments: Other: Non-hospitalized and non-emergency care; Other: Non-hospitalized with emergency care; Other: Hospitalized

Study type: Observational

Funder types: Other

Identifiers

NCT05109572

514/194/41

Details and patient eligibility

About

This study aimed to examine the effect of the Covid-19 pandemic on schizophrenia patients registered to the Community Mental Health Center (CMHC) in terms of depression, suicide risk, and tendency to violence.

Full description

The study was conducted on patients registered to the Ministry of Health Kartal Dr. Lütfi Kırdar City Hospital Adatepe Community Mental Health Center and was followed up regularly. It was carried out on 108 individuals who met the diagnosis of schizophrenia according to the DSM-V (American Psychiatric Association 2013) and met the inclusion criteria. Individuals who were respectively classified as hospitalized group (HG) during the Covid-19 pandemic period (n=39), non-hospitalized with emergency care group (NHECG) without hospitalization (n=37), and non-hospitalized with non-emergency care group (NHNECG) (n=32). Individuals who had been diagnosed with schizophrenia for at least two years, were not in the active phase of the disease, did not have organic mental disorders, did not have any other psychiatric diseases were included in the study. In the study, the Socio-Demographic Questionnaire, the Calgary Depression Scale in Schizophrenia (CDSS), the Buss-perry Aggression Questionnaire (BPAQ), and the Suicide Probability Scale (SPS) were used.

Enrollment: 108 patients

Sex: All

Ages: 18 to 65 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• between the ages of 18-65,
• receiving service from Kartal Dr. Lütfi Kırdar City Hospital Adatepe CMHC,
• having been diagnosed with schizophrenia for at least two years,
• not being in the active phase of the disease,
• not having an organic mental disorder,
• not having an additional psychiatric illness, and
• being literate

Exclusion criteria

• Individuals with cognitive and physical dysfunction,
• mental retardation, different psychiatric diseases that would prevent interview or testing, and
• those who did not consent to participate in the study

Trial design

108 participants in 3 patient groups

Hospitalized group

Description:

Hospitalized patient (HP) stayed in hospital during the Covid-19 pandemic period

Treatment:

Other: Non-hospitalized and non-emergency care

Other: Non-hospitalized with emergency care

Non-hospitalized with Emergency care

Description:

Emergency care plan made but no hospitalization was included to this study during the Covid-19 pandemic period

Treatment:

Other: Non-hospitalized and non-emergency care

Other: Hospitalized

Non-hospitalized and non-emergency care

Description:

Patients who neither apply to the emergency department nor are hospitalized was included to this study during the Covid-19 pandemic period

Treatment:

Other: Hospitalized